• Skip to primary navigation
  • Skip to main content
  • Skip to footer
  • LinkedIn
  • YouTube
  • Instagram
  • X
  • Contact Us
  • Clinical Trials
  • Careers
  • Investors
Insmed Insmed

Insmed

  • Company

    Company

    Get to know Insmed, see what drives us, and learn how weโ€™re building a company where people come first.

    Learn about our company

    • Culture
    • What Guides Us
    • Management Team
    • Board of Directors
    • Partnerships

    Our Global Company

    Find available career opportunities in the U.S., Japan, or Europe.

    Find Jobs

  • Patients

    Patients

    See how we collaborate with patients to shape every step of our shared journey.

    Learn about our
    commitment to patients

    • Disease Areas
    • Patient Advocacy & Resources
    • Patient Access

    Current Clinical Trials

    Learn more about our clinical trials or find a relevant trial near you.

    See if you may qualify

  • Science

    Science

    Discover the innovative science that fuels our commitment to delivering breakthroughs.

    Learn about our science

    • Pipeline
    • Areas of Innovation
      • Gene Therapy with Targeted Delivery
      • Protein Deimmunization
      • RNA End-Joining
      • Synthetic Rescue
    • Investigator-Initiated Research
    • Grants & Funding
  • Therapies

    Therapies

    Learn about our therapies

    • ARIKAYCEยฎ
    • BRINSUPRIยฎ
  • Responsibility

    Responsibility

    See how weโ€™re continuing to advance science sustainably and ethically.

    Learn about our
    commitment to responsibility

      • Global Healthcare Compliance
      • Policies & Disclosures

    Responsibility in Action

    Our commitment to responsibility reflects the culture and purpose we live by every day.

    Visit our Responsibility site

  • Company
    • Company
    • Culture
    • What Guides Us
    • Management Team
    • Board of Directors
    • Partnerships
  • Patients
    • Patients
    • Disease Areas
    • Patient Advocacy & Resources
    • Patient Access
  • Science
    • Science
    • Pipeline
    • Areas of Innovation
      • Gene Therapy with Targeted Delivery
      • Protein Deimmunization
      • RNA End-Joining
      • Synthetic Rescue
    • Investigator-Initiated Research
    • Grants & Funding
  • Therapies
    • Therapies
    • ARIKAYCEยฎ
      BRINSUPRIยฎ
  • Responsibility
    • Responsibility
    • Global Healthcare Compliance
    • Policies & Disclosures
  • Investors
  • Press Releases
  • Events & Presentations
  • Financials & Filings
    • Earnings Results
    • Annual Reports
    • SEC Filings
  • Corporate Governance
  • Responsibility Reports
  • Resources
    • Stock Information
    • Investor FAQs
    • Analyst Coverage
    • Email Alerts

Press Releases

Month Year
Su Mo Tu We Th Fr Sa
Month Year
Su Mo Tu We Th Fr Sa
Email Alerts
Advanced Search
  
Asset Types
           
 Basic Search
  • Dec 26, 2008
    Insmed to Appeal Delisting Notification From Nasdaq

    Read more

  • Dec 23, 2008
    Insmed Announces that NASDAQ Extends Temporary Suspension of Minimum Bid Closing Price Rule

    Read more

  • Nov 25, 2008
    Insmed to Present at Sanford C. Bernstein Biosimilars Long View Conference

    Read more

  • Nov 18, 2008
    Insmed to Participate in Federal Trade Commission Roundtable on Follow-on Biologic Drugs: Framework for Competition and Continued Innovation

    Read more

  • Nov 10, 2008
    Insmed Gains Royalty-Free Worldwide Rights for IPLEX(TM) in Connection with Potential Expanded Access ALS Programs

    Read more

  • Nov 5, 2008
    Insmed to Present at Upcoming Healthcare Conferences

    Read more

  • Oct 30, 2008
    Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008
    Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008
    • Photos 4

    Read more

  • Oct 22, 2008
    NASDAQ's Temporary Suspension of Minimum Bid Closing Price Rules Extends Insmed's Compliance Date to March 20, 2009

    Read more

  • Oct 21, 2008
    Insmed Announces That NASDAQ Temporarily Suspends Minimum Bid Closing Price Rule

    Read more

  • Oct 20, 2008
    Insmed to Host Third Quarter 2008 Conference Call

    Read more

  • Oct 14, 2008
    Insmed Initiates Clinical Study for Follow-on Biologic Version of Neulasta(R)

    Read more

  • Oct 14, 2008
    Insmed to Seek Shareholder Approval for Reverse Split

    Read more

  • Sep 23, 2008
    Insmed and Premacure Cite Study Results Demonstrating Potential Effectiveness of IPLEX(TM) in Preventing Blindness in Premature Infants

    Read more

  • Sep 15, 2008
    Insmed to Present at Biosimilars 2008 Conference

    Read more

  • Sep 4, 2008
    Insmed to Present at BioPharm Asia 2008 Conference

    Read more

  • Sep 3, 2008
    NASDAQ Hearing Panel Grants Insmed Request for Continued Listing on the NASDAQ Stock Market

    Read more

  • Aug 8, 2008
    Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008

    Read more

  • Jul 28, 2008
    Jim Miller, Ph.D. Joins Insmed Therapeutic Proteins as Vice President of Process Development

    Read more

  • Jul 25, 2008
    Insmed to Host Second Quarter 2008 Conference Call

    Read more

  • Jul 25, 2008
    Insmed CEO to Present at Drug Discovery & Development Conference

    Read more

  • Jul 22, 2008
    Insmed CEO to Present at Congressional Briefing on Follow-On Biologics

    Read more

  • Jul 21, 2008
    Insmed Provides Update on IPLEX(TM) Programs

    Read more

  • Jul 17, 2008
    Insmed Partners With Bill Thomas, Former House Ways and Means Chairman, as Strategic Advisor

    Read more

  • Jul 14, 2008
    Insmed Retains RBC Capital Markets as Strategic Financial Advisor

    Read more

  • Jul 10, 2008
    Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company

    Read more

Show 5102550100 per page
  • «
  • 1
  • …
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 31
  • »
Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your email alerts.

Sign Up

Investor Presentation

View the latest Insmed Investor Presentation

Download

Footer

Insmed

LinkedIn YouTube Instagram X

Terms of Use Privacy Policy California Notice at Collection U.S. Consumer Health Data Privacy Policy Your Privacy ChoicesCookie Settings

ยฉ 2026 Insmed Incorporated. All Rights Reserved.

You are now leaving Insmed's website.

Insmed does not control, review, or endorse third-party websites, and you agree that Insmed is not responsible for the content of the website you are about to enter.